Cynata Therapeutics Limited Stock Price on October 3, 2024
CYYNF Stock | USD 0.19 0.00 0.00% |
If you're considering investing in Cynata Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Cynata Therapeutics stands at 0.19, as last reported on the 11th of December 2024, with the highest price reaching 0.19 and the lowest price hitting 0.19 during the day. We have found three technical indicators for Cynata Therapeutics Limited, which you can use to evaluate the volatility of the firm.
Cynata Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Cynata |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
CYYNF |
Based on monthly moving average Cynata Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cynata Therapeutics by adding Cynata Therapeutics to a well-diversified portfolio.
Related Headline
Lexaria Bioscience Headline on 3rd of October 2024
Disposition of 200000 shares by Richard Christopher of Lexar... by Richard Christopher
Filed transaction by Lexaria Bioscience Corp Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Cynata Therapeutics Valuation on October 3, 2024
It is possible to determine the worth of Cynata Therapeutics on a given historical date. On October 3, 2024 Cynata was worth 0.19 at the beginning of the trading date compared to the closed value of 0.19. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cynata Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Cynata Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cynata Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cynata Therapeutics' related companies.
Open | High | Low | Close | Volume | |
0.19 | 0.19 | 0.19 | 0.19 | 1.00 | |
10/03/2024 | 0.19 | 0.19 | 0.19 | 0.19 | 1.00 |
0.19 | 0.19 | 0.19 | 0.19 | 1.00 |
Backtest Cynata Therapeutics | | | Cynata Therapeutics History | | | Cynata Therapeutics Valuation | Previous | Next |
Cynata Therapeutics Trading Date Momentum on October 3, 2024
On October 04 2024 Cynata Therapeutics Limited was traded for 0.19 at the closing time. The highest daily price throughout the period was 0.19 and the lowest price was 0.19 . There was no trading activity during the period 1.0. Lack of trading volume on 10/04/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Cynata Therapeutics Fundamentals Correlations and Trends
By evaluating Cynata Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cynata Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cynata financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cynata Therapeutics Pink Sheet history
Cynata Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cynata is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cynata Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cynata Therapeutics stock prices may prove useful in developing a viable investing in Cynata Therapeutics
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. Cynata Therapeutics Limited was founded in 2011 and is based in Cremorne, Australia. Cynata Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange.
Cynata Therapeutics Pink Sheet Technical Analysis
Cynata Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Cynata Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Cynata Therapeutics Limited cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cynata Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Cynata Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cynata Therapeutics shares will generate the highest return on investment. By undertsting and applying Cynata Therapeutics pink sheet market strength indicators, traders can identify Cynata Therapeutics Limited entry and exit signals to maximize returns
Complementary Tools for Cynata Pink Sheet analysis
When running Cynata Therapeutics' price analysis, check to measure Cynata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cynata Therapeutics is operating at the current time. Most of Cynata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cynata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cynata Therapeutics' price. Additionally, you may evaluate how the addition of Cynata Therapeutics to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |